OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials
Edoardo Mannucci, Ilaria Dicembrini, Besmir Nreu, et al.
Diabetes Obesity and Metabolism (2019) Vol. 22, Iss. 2, pp. 203-211
Closed Access | Times Cited: 42
Edoardo Mannucci, Ilaria Dicembrini, Besmir Nreu, et al.
Diabetes Obesity and Metabolism (2019) Vol. 22, Iss. 2, pp. 203-211
Closed Access | Times Cited: 42
Showing 26-50 of 42 citing articles:
Effects of insulin on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
Edoardo Mannucci, Giovanni Targher, Besmir Nreu, et al.
Nutrition Metabolism and Cardiovascular Diseases (2022) Vol. 32, Iss. 6, pp. 1353-1360
Open Access | Times Cited: 11
Edoardo Mannucci, Giovanni Targher, Besmir Nreu, et al.
Nutrition Metabolism and Cardiovascular Diseases (2022) Vol. 32, Iss. 6, pp. 1353-1360
Open Access | Times Cited: 11
Metabolic improvement with short‐term, glucagon‐like peptide‐1 receptor agonist treatment does not improve cardiac diastolic dysfunction in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial
Annemie Stege Bojer, Martin Heyn Sørensen, Jenny Bjerre, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 10, pp. 2374-2384
Closed Access | Times Cited: 12
Annemie Stege Bojer, Martin Heyn Sørensen, Jenny Bjerre, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 10, pp. 2374-2384
Closed Access | Times Cited: 12
Comparison of mechanistic pathways of bariatric surgery in patients with diabetes mellitus: A B ayesian network meta‐analysis
Chaoxing Lin, Trevor James Jun‐Ming Yeong, Wen Hui Lim, et al.
Obesity (2022) Vol. 30, Iss. 7, pp. 1380-1390
Closed Access | Times Cited: 8
Chaoxing Lin, Trevor James Jun‐Ming Yeong, Wen Hui Lim, et al.
Obesity (2022) Vol. 30, Iss. 7, pp. 1380-1390
Closed Access | Times Cited: 8
Current gaps in management and timely referral of cardiorenal complications among people with type 2 diabetes mellitus in the Middle East and African countries: Expert recommendations
Alper Sönmez, Hani Sabbour, Akram Echtay, et al.
Journal of Diabetes (2022) Vol. 14, Iss. 5, pp. 315-333
Open Access | Times Cited: 7
Alper Sönmez, Hani Sabbour, Akram Echtay, et al.
Journal of Diabetes (2022) Vol. 14, Iss. 5, pp. 315-333
Open Access | Times Cited: 7
Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors
Katherine Young, Eram Haider McInnes, Robert Massey, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Katherine Young, Eram Haider McInnes, Robert Massey, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Diabetes and cardiovascular risk according to sex: An overview of epidemiological data from the early Framingham reports to the cardiovascular outcomes trials
Abdallah Al‐Salameh, Nacera El bouzegaoui, M. Saraval-Gross
Annales d Endocrinologie (2022) Vol. 84, Iss. 1, pp. 57-68
Open Access | Times Cited: 5
Abdallah Al‐Salameh, Nacera El bouzegaoui, M. Saraval-Gross
Annales d Endocrinologie (2022) Vol. 84, Iss. 1, pp. 57-68
Open Access | Times Cited: 5
Glucose‐lowering pharmacotherapies in Chinese adults with type 2 diabetes and cardiovascular disease or chronic kidney disease. An expert consensus reported by the Chinese Diabetes Society and the Chinese Society of Endocrinology
Tianpei Hong, Qing Su, M Kellis, et al.
Diabetes/Metabolism Research and Reviews (2020) Vol. 37, Iss. 4
Closed Access | Times Cited: 7
Tianpei Hong, Qing Su, M Kellis, et al.
Diabetes/Metabolism Research and Reviews (2020) Vol. 37, Iss. 4
Closed Access | Times Cited: 7
Heart failure outcomes and glucagon-like peptide-1 receptor agonists: A systematic review of observational studies
Omar S. Alkhezi, Haifa A Alsuhaibani, Amal A Alhadyab, et al.
Primary care diabetes (2021) Vol. 15, Iss. 5, pp. 761-771
Closed Access | Times Cited: 7
Omar S. Alkhezi, Haifa A Alsuhaibani, Amal A Alhadyab, et al.
Primary care diabetes (2021) Vol. 15, Iss. 5, pp. 761-771
Closed Access | Times Cited: 7
GLP-1 receptor agonists and cardiovascular outcomes in patients with type 2 diabetes: Clinical evidence and best practice
Lola A. Coke, Prakash Deedwania, Debbie Hinnen, et al.
Journal of the American Association of Nurse Practitioners (2022) Vol. 34, Iss. 2, pp. 418-440
Open Access | Times Cited: 4
Lola A. Coke, Prakash Deedwania, Debbie Hinnen, et al.
Journal of the American Association of Nurse Practitioners (2022) Vol. 34, Iss. 2, pp. 418-440
Open Access | Times Cited: 4
Non-targeted metabolomic analysis predicts the therapeutic effects of exenatide on endothelial injury in patients with type 2 diabetes
Jin Yang, Yunyi Le, Tianjiao Wei, et al.
Journal of Diabetes and its Complications (2020) Vol. 35, Iss. 2, pp. 107797-107797
Closed Access | Times Cited: 5
Jin Yang, Yunyi Le, Tianjiao Wei, et al.
Journal of Diabetes and its Complications (2020) Vol. 35, Iss. 2, pp. 107797-107797
Closed Access | Times Cited: 5
Evaluation of Consistency of Treatment Response Across Regions—the LEADER Trial in Relation to the ICH E17 Guideline
Henrik Kim Nielsen, Stephanie DeChiaro, Bryan Goldman
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 5
Henrik Kim Nielsen, Stephanie DeChiaro, Bryan Goldman
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 5
Role of Incretin Mimetics in Cardiovascular Outcomes and Other Classical Cardiovascular Risk Factors beyond Obesity and Diabetes Mellitus in Nondiabetic Adults with Obesity: a Meta-analysis of Randomized Controlled Trials
William Kamarullah, Raymond Pranata, Siska Wiramihardja, et al.
American Journal of Cardiovascular Drugs (2024)
Closed Access
William Kamarullah, Raymond Pranata, Siska Wiramihardja, et al.
American Journal of Cardiovascular Drugs (2024)
Closed Access
Pharmacotherapy for Obesity: Recent Evolution and Implications for Cardiovascular Risk Reduction
Kevin C. Maki, Carol F. Kirkpatrick, David B. Allison, et al.
Contemporary cardiology (2024), pp. 319-343
Closed Access
Kevin C. Maki, Carol F. Kirkpatrick, David B. Allison, et al.
Contemporary cardiology (2024), pp. 319-343
Closed Access
Redefining Cardiovascular (CV) Death as a Primary Endpoint Component in Cardiovascular Outcome Trials
Samit Ghosal, Binayak Sinha
Current Diabetes Reviews (2020) Vol. 16, Iss. 9, pp. 917-921
Closed Access | Times Cited: 2
Samit Ghosal, Binayak Sinha
Current Diabetes Reviews (2020) Vol. 16, Iss. 9, pp. 917-921
Closed Access | Times Cited: 2
Semaglutide for the Management of type 2 Diabetes: Clinical Evidence, Cardioprotective Effects, and Guidelines
Zhanna Kobalava, Е. В. Кохан
Kardiologiia (2020) Vol. 60, Iss. 9, pp. 122-133
Open Access | Times Cited: 2
Zhanna Kobalava, Е. В. Кохан
Kardiologiia (2020) Vol. 60, Iss. 9, pp. 122-133
Open Access | Times Cited: 2
Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials
Gad Cotter, Beth A. Davison, Christopher Edwards, et al.
American Heart Journal (2021) Vol. 240, pp. 73-80
Open Access | Times Cited: 2
Gad Cotter, Beth A. Davison, Christopher Edwards, et al.
American Heart Journal (2021) Vol. 240, pp. 73-80
Open Access | Times Cited: 2
Utilisation and expenditure on glucose-lowering drugs used for the treatment of type 2 diabetes mellitus in Ireland, a repeated cross-sectional study
Amelia Smith, Carmel Kennedy, Sarah Clarke, et al.
Diabetes Epidemiology and Management (2021) Vol. 5, pp. 100038-100038
Open Access | Times Cited: 2
Amelia Smith, Carmel Kennedy, Sarah Clarke, et al.
Diabetes Epidemiology and Management (2021) Vol. 5, pp. 100038-100038
Open Access | Times Cited: 2
Applications of Clinical Decision Support Systems in Diabetes Care: Scoping Review (Preprint)
Shan Huang, Yuzhen Liang, Jiarui Li, et al.
(2023)
Open Access
Shan Huang, Yuzhen Liang, Jiarui Li, et al.
(2023)
Open Access
